Drug-Driven Synthetic Lethality: Bypassing Tumor Cell Genetics with a Combination of AsiDNA and PARP InhibitorsWael Jdey, Marie Dutreix, Sylvain Thierry et al.|Clinical Cancer Research|2016Cited by 42
Abstract 1110: AsiDNA induce tumor sensitivity to PARP inhibitors in homologous recombination proficient breast cancer AsiDNA induce tumor sensitivity to PARP inhibitors in homologous recombination proficient breast cancerM. Dutreix, Graham Dixon, Wael Jdey et al.|Cancer Research|2017Cited by 0
Data from Drug-Driven Synthetic Lethality: Bypassing Tumor Cell Genetics with a Combination of AsiDNA and PARP InhibitorsWael Jdey, Marie Dutreix, Sylvain Thierry et al.|Unknown|2023Cited by 0
Supplementary figure S2 from Drug-Driven Synthetic Lethality: Bypassing Tumor Cell Genetics with a Combination of AsiDNA and PARP InhibitorsWael Jdey, Marie Dutreix, Sylvain Thierry et al.|Unknown|2023Cited by 0
Supplementary figure S1 from Drug-Driven Synthetic Lethality: Bypassing Tumor Cell Genetics with a Combination of AsiDNA and PARP InhibitorsWael Jdey, Marie Dutreix, Sylvain Thierry et al.|Unknown|2023Cited by 0